Day: September 1, 2025

Vilnius, Lithuania, Sept. 01, 2025 (GLOBE NEWSWIRE) — As at the end of August 2025, the net asset value (NAV) of SUTNTIB AB Tewox decreased to EUR 45,641,043, compared to the previously determined NAV of EUR 46,025,174 at the end of July 2025. The share price decreased to EUR 1.0902, from EUR 1.0994 at the end of July 2025. The pro-forma internal rate of return (IRR) decreased to 3.73%, compared to previously announced IRR of 4.09% at the end of July 2025. Contact person for further information: Paulius Nevinskas Manager of the Investment Company paulius.nevinskas@lordslb.lt https://lordslb.lt/tewox_bonds/

3D rendering BDNBay du Nord FPSOSigns Head of Agreement with Equinor for Bay du Nord FPSO BW Offshore has signed a Head of Agreement (HoA) with Equinor Canada Ltd, confirming its selection as preferred bidder for the Floating Production, Storage and Offloading (FPSO) unit for the Bay du Nord project offshore Newfoundland and Labrador, Canada. Bay du Nord, Canada’s first deepwater oil project, is operated by Equinor in partnership with BP and holds an estimated 400 million barrels of recoverable light crude in its initial phase. Under the HoA, BW Offshore and Equinor will continue to advance discussions on all technical and commercial aspects of the FPSO project. These include further maturation of a smart and cost-effective design through Front End Engineering Design (FEED) work, and agreeing on a commercial solution. The FPSO...

MONTREAL, Sept. 01, 2025 (GLOBE NEWSWIRE) — Cannara Biotech Inc. (“Cannara”, “the Company”, “us” or “we”) (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis products at disruptive prices with two mega facilities based in Québec spanning over 1,650,000 sq. ft., today announced that its board of directors has approved the grant of incentive awards under the Company’s stock option plan (the “Stock Option Plan”), and restricted share unit compensation plan (the “RSU Plan”) (collectively, the “Incentive Plans”). The awards were granted aligning with the completion of the Company’s fiscal year-end on August 31, 2025, which marked five consecutive years of commercial operations and year-over-year revenue growth since launching its cannabis business. In accordance with and subject to the...

  Pharma Equity Group’s subsidiary, Reponex Pharmaceuticals A/S, receives regulatory approval to initiate pivotal clinical trial with RNX-011 for life-threatening peritonitis Copenhagen, September 01, 2025 Company Announcement No. 10 Reponex Pharmaceuticals A/S (Reponex), a subsidiary of Pharma Equity Group A/S (NASDAQ: PEG), today announced that it has received regulatory approval to initiate a pivotal Phase 2 clinical trial with its drug candidate RNX-011. The study will investigate the treatment of secondary peritonitis, a serious and life-threatening intra-abdominal infection with high mortality. The approval is a fundamental milestone for the company and a validation of the scientific strategy for RNX-011. The study addresses a critical unmet medical need in emergency abdominal surgery, where patient outcomes remain poor and...

HONG KONG, Sept. 01, 2025 (GLOBE NEWSWIRE) — GPTBots.ai, a leading enterprise-grade AI agent building platform. Breaking Boundaries in Digital Transformation: How Traditional Manufacturers Are Building Smarter, More Efficient Customer Service Systems. The collaboration between GP Batteries, a global leader in battery manufacturing, and GPTBots.ai, an enterprise-grade no-code AI agent platform, sets a benchmark for the industry.Image Source: https://formaplus.rs/ The Customer Service Challenge for Battery Experts: Complex Products + Multilingual Markets Headquartered in Hong Kong, GP Batteries was established in the 1960s and operates in over 50 countries and regions worldwide. Its product portfolio includes AA, AAA, CR2032, CR2025, rechargeable batteries, specialty batteries, and more, widely used in household appliances, tools,...

        Company Announcement No 40/2025Peberlyk 46200 AabenraaDenmark Tel +45 74 37 37 37Fax +45 74 37 35 36 Sydbank A/SCVR No DK 12626509, Aabenraasydbank.dk1 September 2025  Dear Sirs Sydbank A/S share buyback programme: transactions in week 35On 26 February 2025 Sydbank A/S announced a share buyback programme of DKK 1,350m. The share buyback programme commenced on 3 March 2025 and will be completed by 31 January 2026. The purpose of the share buyback programme is to reduce the share capital of Sydbank A/S and the programme is executed in compliance with the provisions of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 and Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, collectively referred to as the Safe Harbour rules. The following transactions have been made...

                 Atos Group strengthens its management team to further execute and accelerate its transformation plan Paris, France – September 1, 2025 – Atos Group, a leading provider of AI-powered digital transformation, today announces the appointments of four senior executives to strengthen its executive team. These seasoned leaders will join the leadership management team and support the next phase of the Group’s fast-moving transformation plan to restore sustainable profitable growth, improve performance, and create long-term value for all stakeholders. Philippe Salle, Atos Group Chairman and CEO says: “I am pleased to welcome these world-class leaders to our team, a significant addition to further bolster our management team. With the Group’s financial structure secure, their leadership and experience in their respective areas...